212 related articles for article (PubMed ID: 28752131)
1. Multiple Administrations of Viral Nanoparticles Alter
Shukla S; Dorand RD; Myers JT; Woods SE; Gulati NM; Stewart PL; Commandeur U; Huang AY; Steinmetz NF
ACS Biomater Sci Eng; 2016 May; 2(5):829-837. PubMed ID: 28752131
[TBL] [Abstract][Full Text] [Related]
2. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
3. Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy.
Le DH; Lee KL; Shukla S; Commandeur U; Steinmetz NF
Nanoscale; 2017 Feb; 9(6):2348-2357. PubMed ID: 28144662
[TBL] [Abstract][Full Text] [Related]
4. Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers.
Shukla S; Myers JT; Woods SE; Gong X; Czapar AE; Commandeur U; Huang AY; Levine AD; Steinmetz NF
Biomaterials; 2017 Mar; 121():15-27. PubMed ID: 28063980
[TBL] [Abstract][Full Text] [Related]
5. Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity.
Merwaiss F; Lozano-Sanchez E; Zulaica J; Rusu L; Vazquez-Vilar M; Orzáez D; Rodrigo G; Geller R; Daròs JA
Plant Biotechnol J; 2024 Apr; 22(4):876-891. PubMed ID: 37966715
[TBL] [Abstract][Full Text] [Related]
6. Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens.
Li B; Chu F; Lu Q; Wang Y; Lane LA
Acta Biomater; 2021 Feb; 121():527-540. PubMed ID: 33285326
[TBL] [Abstract][Full Text] [Related]
7. Interactions Between Plant Viral Nanoparticles (VNPs) and Blood Plasma Proteins, and Their Impact on the VNP In Vivo Fates.
Pitek AS; Veliz FA; Jameson SA; Steinmetz NF
Methods Mol Biol; 2018; 1776():591-608. PubMed ID: 29869268
[TBL] [Abstract][Full Text] [Related]
8. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of plant virus nanoparticles.
Nkanga CI; Steinmetz NF
Virology; 2021 Apr; 556():39-61. PubMed ID: 33545555
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.
Pitek AS; Jameson SA; Veliz FA; Shukla S; Steinmetz NF
Biomaterials; 2016 May; 89():89-97. PubMed ID: 26950168
[TBL] [Abstract][Full Text] [Related]
11. Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists.
Stavnsbjerg C; Christensen E; Münter R; Henriksen JR; Fach M; Parhamifar L; Christensen C; Kjaer A; Hansen AE; Andresen TL
J Control Release; 2022 Feb; 342():337-344. PubMed ID: 34973307
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of Filamentous Plant Virus Nanoparticles: Pepino Mosaic Virus versus Potato Virus X.
Le DHT; Méndez-López E; Wang C; Commandeur U; Aranda MA; Steinmetz NF
Biomacromolecules; 2019 Jan; 20(1):469-477. PubMed ID: 30516960
[TBL] [Abstract][Full Text] [Related]
13. Insights From Dynamic Neuro-Immune Imaging on Murine Immune Responses to CNS Damage.
Dorand RD; Benson BL; Huang LF; Petrosiute A; Huang AY
Front Neurosci; 2019; 13():737. PubMed ID: 31379488
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive monitoring of nanoparticle clearance and aggregation in blood circulation by in vivo flow cytometry.
Wei D; Pang K; Song Q; Suo Y; He H; Weng X; Gao X; Wei X
J Control Release; 2018 May; 278():66-73. PubMed ID: 29625160
[TBL] [Abstract][Full Text] [Related]
15. Plant molecular farming of virus-like nanoparticles as vaccines and reagents.
Rybicki EP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1587. PubMed ID: 31486296
[TBL] [Abstract][Full Text] [Related]
16. Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy.
Hak S; Cebulla J; Huuse EM; Davies Cde L; Mulder WJ; Larsson HB; Haraldseth O
Angiogenesis; 2014 Jan; 17(1):93-107. PubMed ID: 23982332
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.
Wu Y; Li J; Shin HJ
Biotechnol Bioprocess Eng; 2021; 26(1):25-38. PubMed ID: 33584104
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.
Shukla S; Wen AM; Ayat NR; Commandeur U; Gopalkrishnan R; Broome AM; Lozada KW; Keri RA; Steinmetz NF
Nanomedicine (Lond); 2014 Feb; 9(2):221-35. PubMed ID: 23834501
[TBL] [Abstract][Full Text] [Related]
19. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
[TBL] [Abstract][Full Text] [Related]
20. Next-generation viral nanoparticles for targeted delivery of therapeutics: Fundamentals, methods, biomedical applications, and challenges.
Tan JS; Jaffar Ali MNB; Gan BK; Tan WS
Expert Opin Drug Deliv; 2023; 20(7):955-978. PubMed ID: 37339432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
